United Capital Financial Advisors LLC Buys New Holdings in Danaher Corporation $DHR

United Capital Financial Advisors LLC purchased a new position in Danaher Corporation (NYSE:DHR) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 13,726 shares of the conglomerate’s stock, valued at approximately $9,884,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. High Note Wealth LLC raised its holdings in shares of Danaher by 19.2% in the 4th quarter. High Note Wealth LLC now owns 292 shares of the conglomerate’s stock valued at $67,000 after purchasing an additional 47 shares in the last quarter. First Command Advisory Services Inc. grew its stake in shares of Danaher by 4.4% during the fourth quarter. First Command Advisory Services Inc. now owns 1,104 shares of the conglomerate’s stock worth $253,000 after purchasing an additional 47 shares in the last quarter. GW&K Investment Management LLC increased its holdings in Danaher by 8.4% in the fourth quarter. GW&K Investment Management LLC now owns 605 shares of the conglomerate’s stock valued at $138,000 after buying an additional 47 shares during the last quarter. Kestra Private Wealth Services LLC raised its stake in Danaher by 0.3% in the third quarter. Kestra Private Wealth Services LLC now owns 15,421 shares of the conglomerate’s stock valued at $3,057,000 after buying an additional 48 shares in the last quarter. Finally, SOL Capital Management CO raised its stake in Danaher by 2.7% in the fourth quarter. SOL Capital Management CO now owns 1,879 shares of the conglomerate’s stock valued at $430,000 after buying an additional 50 shares in the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on DHR. Citigroup began coverage on Danaher in a report on Tuesday, May 26th. They set a “buy” rating and a $230.00 price target for the company. DZ Bank assumed coverage on Danaher in a research report on Wednesday, June 3rd. They set a “buy” rating and a $210.00 target price on the stock. Evercore restated an “outperform” rating and set a $230.00 target price on shares of Danaher in a research note on Monday, July 6th. Piper Sandler began coverage on Danaher in a report on Thursday, June 11th. They issued a “neutral” rating and a $200.00 price target for the company. Finally, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $240.00 price target on shares of Danaher in a research note on Wednesday, July 22nd. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat, Danaher has an average rating of “Moderate Buy” and an average price target of $228.91.

Danaher Stock Performance

Shares of DHR opened at $215.74 on Friday. The stock has a market capitalization of $151.67 billion, a P/E ratio of 38.32, a P/E/G ratio of 2.68 and a beta of 0.78. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80. The company’s fifty day moving average is $198.69 and its two-hundred day moving average is $192.35.

Danaher (NYSE:DHR) last released its earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping the consensus estimate of $1.85 by $0.09. The company had revenue of $6.26 billion during the quarter, compared to analysts’ expectations of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business’s revenue was up 5.5% on a year-over-year basis. During the same quarter last year, the business earned $0.77 EPS. On average, sell-side analysts predict that Danaher Corporation will post 8.53 earnings per share for the current year.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.